Literature DB >> 9754765

Bilateral non-familial renal cell carcinoma.

G Grimaldi1, V Reuter, P Russo.   

Abstract

BACKGROUND: Bilateral renal cell carcinoma (RCC) exists in hereditary forms (von Hippel-Lindau disease, hereditary papillary renal cell carcinoma, and hereditary clear cell renal carcinoma) associated with various chromosomal abnormalities, and non-hereditary, apparently sporadic forms. The focus of this study is the clinical description of the latter entity.
METHODS: Synchronous and asynchronous bilateral RCC were identified from a prospective database of 698 consecutive patients undergoing operation for RCC between July 1989 and December 1997 at Memorial Sloan-Kettering Cancer Center. Non-familial RCC was defined as that occurring in those patients without a family or hereditary history of RCC. Patients' records were evaluated for presentation, surgical approach used, and pathology. Actuarial survival from the date of initial operative treatment until the date of last follow-up or death was determined using the Kaplan-Meier method. Comparisons between groups were made using the Mann-Whitney test.
RESULTS: Thirty-three of 698 (4.7%) patients operated for RCC had bilateral disease. Four of the 33 (12.1%) patients had either VHL or documented hereditary RCC, and 29 of 33 (87.9%) had non-familial RCC. Of the 29 patients, histology was conventional (clear cell) in 17 patients, papillary in 5, oncocytoma in 3, and unclassified in 3. One patient had a conventional (clear cell) histology in the first nephrectomy specimen and chromophobe renal cell carcinoma in the second. Partial nephrectomy was used in 100% of patients. Median follow-up time was 52 months. Actuarial 5-year overall survival was 84.5%, and actuarial disease-specific survival was 93.3% at 5 years for the non-familial RCC patients.
CONCLUSIONS: Non-familial bilateral RCC patients represent a distinct subpopulation of renal cancer patients with a good overall prognosis. Partial nephrectomy is an integral part of the surgical management. Although most bilateral tumors present synchronously, asynchronous lesions may occur many years after original nephrectomy, thus committing the patient to long-term follow-up.

Entities:  

Mesh:

Year:  1998        PMID: 9754765     DOI: 10.1007/bf02303649

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  16 in total

Review 1.  Long-term management of bilateral, multifocal, recurrent renal carcinoma.

Authors:  Gennady Bratslavsky; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

Review 2.  Radiofrequency ablation of renal tumors.

Authors:  Michael J Stone; Aradhana M Venkatesan; Julia Locklin; Peter Pinto; Marston Linehan; Bradford J Wood
Journal:  Tech Vasc Interv Radiol       Date:  2007-06

3.  Bilateral renal cell carcinoma with leiomyomatous stroma: A rare entity diagnosed synchronously and treated surgically in a staged fashion.

Authors:  Murat Can Kiremit; Ömer Acar; Yeşim Sağlıcan; Tarık Esen
Journal:  Turk J Urol       Date:  2017-12-01

4.  Non-Familial Synchronous Bilateral Renal Cell Carcinoma with Bilateral Synchronous Renal Vein Extension and Inferior Vena Cava Thrombus.

Authors:  Wilson Lin; Kara L Watts; Meenakshi Davuluri; Ahmed Aboumohamed
Journal:  Curr Urol       Date:  2019-09-10

5.  Contrast enhanced ultrasound of renal masses.

Authors:  Andre Ignee; Bernd Straub; Gudrun Schuessler; Christoph Frank Dietrich
Journal:  World J Radiol       Date:  2010-01-28

Review 6.  [Imperative nephron-sparing surgery for cases of solitary kidney/bilateral tumors: long-term results].

Authors:  F C Roos; S Pahernik; A Elsässer; A Victor; W Brenner; J W Thüroff
Journal:  Urologe A       Date:  2008-07       Impact factor: 0.639

7.  Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup.

Authors:  Eric A Singer; Srinivas Vourganti; Kelly Y Lin; Gopal N Gupta; Peter A Pinto; Ardeshir R Rastinehad; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2012-10-18       Impact factor: 7.450

Review 8.  Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function.

Authors:  Łukasz Mielczarek; Anna Brodziak; Paweł Sobczuk; Maciej Kawecki; Agnieszka Cudnoch-Jędrzejewska; Anna M Czarnecka
Journal:  Cancer Chemother Pharmacol       Date:  2021-03-25       Impact factor: 3.333

9.  Evaluation of functional outcome of bilateral kidney tumors after sequential surgery.

Authors:  Jung Kwon Kim; Hwanik Kim; Hakmin Lee; Jong Jin Oh; Sangchul Lee; Sung Kyu Hong; Cheol Kwak; Seok-Soo Byun
Journal:  BMC Cancer       Date:  2021-05-24       Impact factor: 4.430

Review 10.  Localized renal cell carcinoma.

Authors:  P Russo
Journal:  Curr Treat Options Oncol       Date:  2001-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.